This review aims to introduce neurally-adjusted ventilatory assist (NAVA) to readers who do not have experience in using this form of ventilation. We will describe the basic principles and theoretical advantages of NAVA together with our experiences of introducing and using this mode in an intensive care unit. Figure 1 Position of the NAVA catheter in relation to the diaphragm.
Introduction
Mechanical ventilation is a life-preserving intervention in a wide range of critical illnesses. Not only is it key to the resuscitation of patients with oxygenation or ventilatory failure from primary lung disease, it is also vital in the support of patients needing augmented oxygen delivery. In our institution, over the latest year analysed, 760 of 2,600 admissions (29%) were ventilated for longer than 48 hours, 379 (15%) for longer than 96 hours and 163 (6%) had tracheostomies performed (Medtrack data, Medical associated software house). Data published by ICNARC emphasises the significant contribution respiratory failure plays to critical illness in the UK. 1 Controlled modes of ventilation, sometimes facilitated by pharmacological muscle relaxation, can be useful to completely replace the patient' s respiratory effort during the initial stages of critical illness and resuscitation. 2 Postresuscitation however, patient-triggered ventilatory support modes in conjunction with the ventilator care bundle are vital to expedite liberation of patients from mechanical ventilation. [3] [4] [5] Provided they are applied optimally, these modes can exercise the respiratory muscles and minimise iatrogenic muscular injury. 6, 7 Several modes of spontaneous ventilatory support have been developed, aiming to strike the balance between beneficial activity and detrimental fatigue, including synchronised intermittent mandatory ventilation (SIMV), pressure support (PS) and proportional assist ventilation (PAV). Here, we describe the newest addition to the stable of support modes, neurally adjusted ventilatory assist (NAVA).
Basic principles and development of NAVA
The NAVA system was first described by Sinderby' s group in 1999, as a way to detect diaphragmatic electrical activity via an adapted nasogastric (NG) tube (the NAVA catheter) and use it to drive a ventilator (Figure 1) . 8 There are two major differences between NAVA and conventional modes of ventilation. The first is that rather than using pneumatic/flow triggering (where the ventilator detects a pressure/flow change in the circuit from patient effort), NAVA uses the neural signal of diaphragmatic electrical activity (EAdi) to initiate the mechanical offloading of respiratory muscles, referred to as neural triggering.
The second difference is that, once initiated, a breath is assisted with pressure support in proportion to the amplitude of the EAdi signal. The EAdi signal is sampled every 16 ms; such rapid sampling enables the ventilator to titrate support throughout the course of every breath as well as between breaths.
The commercial NAVA system is now available on the Servo-I (Maquet) ventilator platform. [9] [10] [11] 
Potential advantages
Data from animal and small-scale human studies, together with individual institutional experience, suggests several potential advantages of NAVA over conventional modes of pressure support, principally through improved synchrony and proportionality of support. [12] [13] [14] However, evidence from randomised controlled trials showing the clinical superiority of NAVA is still lacking.
EAdi as a monitoring tool
Measuring EAdi offers an insight into a patient' s respiratory drive and neural demand for ventilatory support. So long as the NAVA catheter remains in situ and connected to a ventilator, EAdi can be continuously recorded, even in the absence of mechanical ventilation. This ability to constantly monitor EAdi, independent of NAVA' s other role as a novel form of ventilatory support, has enhanced our basic understanding of respiratory physiology in health and disease. 9, [15] [16] [17] [18] [19] [20] The use of NAVA as a monitor in conjunction with the ventilator' s 'NAVA preview' screen (where a predicted NAVA pressure trace is superimposed on the current pressure trace) provides a useful means of introducing the NAVA concept to a naive ICU without committing the team to the mode as a means of ventilation (Figure 2 ).
The ventilator also has the facility to display data from the preceding 24 hours, so can be used to track the trend in EAdi. This has proved very informative when reviewing the impact of ventilatory manoeuvres on respiratory drive (Figure 3 ).
Neural monitoring may well prove to be invaluable in a variety of situations, from pre-empting deterioration on noninvasive ventilation (NIV) or predicting the need for reintubation, through to tracking respiratory recovery and aiding prognostication in spinal cord trauma, as well as facilitating research into diaphragmatic function. 21 One possibility is to quantify the patient' s ability to convert neural demand into tidal ventilation (via a neuro-ventilatory efficiency index) and see whether this can predict failure to wean. 22, 23 Monitoring neural demand may one day enable every patient to have a truly individualised weaning programme, tailored according to the relative impact that mobilisation, airway weaning and ventilatory weaning have on their EAdi.
Improved synchrony
Asynchrony occurs when there is uncoupling of the patient' s neural demand to breathe from the ventilator' s mechanically delivered breaths. It can be a profound barrier to ventilatory weaning, leading to more ventilator days, higher rates of tracheostomy and a trend toward increased patient mortality. 24 Neural triggering has been shown to reduce patient-ventilator asynchrony. [12] [13] [14] [15] Asynchrony can occur during the inspiratory or expiratory phase. 13, 23, 25 Both types of asynchrony become more pronounced with increasing levels of pressure support but not with NAVA. 13, 16, 20 Inspiratory asynchrony occurs during the triggering phase of a breath. It occurs as a result of trigger delay or failure (for example when a patient is weak, has low respiratory drive or is over-inflated) the result of which is that a patient-demanded breath is sensed too late or not at all (Figure 4 ). NAVA, by using neural triggering, overcomes this form of asynchrony and has the added benefit of a faster triggering time. 13 Expiratory asynchrony occurs when 'cycling off' occurs inappropriately, either too early or too late. This results in either prolonged or prematurely discontinued mechanical inflation as compared to the neural respiratory cycle (Figure 4 ). This form of asynchrony has become more readily apparent as a result of EAdi monitoring and has proven to be an impediment to weaning. 9, 13, 26 A third discrete form of asynchrony known as 'flow-assist asynchrony' refers to the discrepancy between the magnitude of neural demand and actual support delivered, which again has become more apparent since neural monitoring has become available.
In our experience 'over-ventilation' (often coupled with over-sedation) proved to be unexpectedly common once we 
Figure 4
Screenshot from a Servo-I ventilator showing overlapping pressure curves; actual pressure curve in pressure support mode (yellow) and theoretical curve if patient were in NAVA mode (white). Inspiratory asynchrony (where neural inspiration begins before flow is triggered), is shown by lack of overlap of the red lines. Expiratory asynchrony (where neural demand starts to fall but the pressure trace shows that mechanical ventilation continues) is shown by lack of overlap of blue lines.
began to monitor EAdi. We have found that initiating EAdi monitoring often leads to an accelerated reduction of support and an earlier ability to challenge patients with spontaneous breathing trials. In our ICU this has resulted in an increase in ventilator-free days in survivors. 27 
Proportionality of support
With conventional pressure support ventilation, the degree of assistance is user-defined and identical for every breath. NAVA support, on the other hand, is adjusted every 16 ms during each breath, which results in a more heterogeneous pressuretime curve. Studies suggest that greater breath-to-breath variability may improve oxygenation and lung mechanics and potentially increase the chance of successful extubation. [28] [29] [30] The relationship between EAdi and pressure support can be augmented by the NAVA level. This offers a 'gain' in the following way:
The clinician can therefore amplify the amount of support offered by the factor of the NAVA level. For example if EAdi is 8 µV and NAVA level set at 2, the patient will receive 16 cm H 2 O pressure support (Figure 5 ).
Protection against ventilator-induced lung injury (VILI)
As it is coupled to the respiratory centre' s output, NAVA takes advantage of the various protective reflexes that exist within the respiratory system to reduce the risk of over-ventilation. 18 Studies in both animals and critically ill patients have demonstrated that even with the application of NAVA levels over and above those required to optimally off-load the respiratory muscles, subjects were able to down-titrate their EAdi to maintain tidal volumes (Vt) in the range of 6-9 mL/kg. 16, 23, 28, 31 Brander et al also investigated biomarkers of biotrauma (IL-8 levels in plasma and lungs) and found them to be reduced in animal models of acute lung injury when comparing NAVA with PS at Vt of 6 mL/kg. 17
Other advantages
Numerous other benefits have been postulated with NAVA ventilation. Chief among these is improved quality of sleep, an important determinant of successful weaning. 32, 33 In a cohort crossover study, patients ventilated with NAVA had a higher proportion of REM sleep and less fragmented sleep. 34
Limitations of NAVA
In order to understand the limitations of NAVA it is important to be aware of the assumptions it makes (Table 1) and its contraindications ( Table 2) . 35 Clinical experience shows that not all patients ventilate appropriately with NAVA; the causes for this are still to be fully understood. 36, 37 In particular, patients with severe adult respiratory distress syndrome (ARDS) often become tachypnoeic and do not have safe tidal volumes despite offloading with high NAVA levels. It is postulated that in such instances, the respiratory centre is overwhelmed by inputs from a myriad of nociceptors, so that despite mechanically offloading the respiratory system there remains an excessive drive to breathe. 38 In such instances, it may be of benefit to disregard central respiratory output and to ventilate the patient with a mandatory mode until the noxious stimuli abate. An 
Basic assumptions
The diaphragm is the primary respiratory muscle and so electrical activity of the diaphragm is equivalent to total neural demand The neuro-ventilatory coupling circuit is intact:
• Output from respiratory centre is present and appropriate alternative strategy may be to remove the noxious stimulus (eg, with extracorporeal CO 2 removal) while maintaining the patient with a spontaneous ventilatory mode. To this end, Karagiannidis et al investigated the use of NAVA with venovenous extracorporeal membrane oxygenation (VV ECMO) in six patients and demonstrated that such a strategy is feasible. 39 In our experience, ARDS is not an absolute contraindication to NAVA and we have successfully used the mode in early ARDS even with oxygenation indices in excess of 20. The optimal strategy seems to require 'opening the lung' and establishing adequate PEEP (using high frequency oscillation and/or muscle relaxants if necessary) and only once recruitment is adequate, making an attempt to acquire EAdi in conjunction with a sedation hold. Using such a strategy, we have had anecdotal success in using NAVA to wean patients with ARDS.
Practical aspects of NAVA ventilation Patient selection
NAVA is a well-tolerated and extremely adaptable technology useful in a wide range of patients, from respiratory to neurological critical illness to those with very poor lung compliance. 23, [39] [40] [41] [42] [43] Overall, it is postulated that NAVA will be of greatest benefit in patients with chronic heart and lung diseases in whom weaning is likely be prolonged or who have previously failed with alternative modes.
There are few absolute contraindications to NAVA ( Table 2) , provided a patient is capable of neurally triggering ventilation. 'Over-ventilation' with conventional ventilatory modes activates central reflexes which cause the respiratory centre to become quiescent and so it may be necessary to reduce support before an EAdi signal can be appreciated. 25 
Signal detection
The technique of NAVA catheter insertion is the same as that of an ordinary NG tube. However, in order to maximise EAdi pick-up, the position of the catheter tip is critical. To this end, two specific tools are used: the Nose-Ear-Xiphoid or 'NEX' measurement provides an estimated catheter insertion length 10 (Figure 6 ) and a 'catheter positioning tool' on the ventilator facilitates optimal placement to maximise EAdi pick-up. Once in situ the NAVA catheter can be used as a standard NG tube for feeding or gastric decompression.
Although NAVA has been used for extended periods, it is important to emphasise the manufacturer' s recommendation of a maximum use period of seven days per catheter. After this, although there is signal fidelity, degradation of the detector array is often visible.
Setting the NAVA level
There are two main methods by which the initial NAVA level can be set. One method is to use the principle of 'equipotence' and choose a NAVA level that produces a Ppeak equivalent to that on conventional ventilation 16 (Figure 7) . This method has the advantage of being easy to achieve so is useful where clinical pressure limits the time available for titration.
An alternative strategy is the titration procedure. 19, 31, 38 With this method, the NAVA level is set at a low level and increased in 0.1 µV increments every 20 seconds while trends in Vt, peak airway pressure (Paw) and EAdi are assessed. Escalating NAVA levels will cause the Vt and Paw to rise and the EAdi to fall as ventilatory support begins to meet neural demand. The Vt and Paw will initially rise steeply but then plateau at a point where the respiratory system is optimally offloaded. The optimal NAVA level is deemed to be at the point of transition to this plateau. 20, 31 Further increasing NAVA beyond this plateau point will lead to a minimal rise in Vt and Paw at the expense of continually falling EAdi. It is important to note that in NAVA mode the EAdi signal will never be totally abolished, even with excessive NAVA levels, but instead the respiratory pattern may become chaotic. 16, 25, 31 This method of NAVA titration is used for research purposes to select precise NAVA levels, and although more accurate, is time-consuming and may be inappropriate in acutely unwell patients. 
Figure 7
Screenshot from Servo-I to demonstrate NAVA level selection. The NAVA level is increased until the estimated NAVA Ppeak is equivalent to that in the current ventilatory mode.
Review articles Triggering and cycling off
Breath triggering with NAVA occurs when EAdi increases by 0.5 µV above the patient' s EAdi(min), this degree of change being higher than variability seen due to external noise. 25 A breath may still be initiated by conventional pneumatic triggers, as triggering occurs on a 'first come, first served' basis. As with other ventilatory modes, the sensitivity of triggers can be altered but our experience shows that this rarely needs changing.
Cycling off is fixed and occurs when the EAdi falls to 70% of peak EAdi (Figure 8 ). Additional parameters may also lead to cycling off; if the upper pressure limit is achieved, if pressure rises by more than 3 cm H 2 O above target inspired pressure or when maximum inspired time limit is exceeded (2.5 seconds for adults). The ventilator also has backup pressure support and pressure control modes (with adjustable defaults) should the EAdi signal be insufficient or apnoea occur.
NAVA and PEEP
With conventional modes of ventilation, patients who have high intrinsic PEEP need to expend significant effort to overcome it in order to trigger the ventilator, leading to a high number of ineffective efforts and increased work of breathing. 14 One approach to combating this is to set a high extrinsic level of PEEP on the ventilator, accepting the potential risks. With NAVA, patients do not have to expend effort overcoming intrinsic PEEP to trigger ventilation so extrinsic PEEP can be set at lower levels.
Evidence suggests that EAdi may be a useful adjunct for titrating PEEP. Specifically, it has been demonstrated that when extrinsic PEEP is inadequate, high levels of EAdi (min) are seen in a phenomenon called 'tonic EAdi.' It is postulated that this is a sign of inadequate PEEP, as it resolves with the application of extrinsic PEEP. 25, 29, 38 Weaning NAVA The optimal strategy for weaning NAVA has yet to be determined and there are several hypotheses. As with all forms of invasive ventilation, the ventilator care bundle remains a vital part of patient management. In particular, consideration of daily sedation holds and spontaneous breathing trials (SBTs) remain invaluable. One approach adopted by Roze et al used EAdi measurements during SBTs to titrate NAVA levels on a daily basis. 44 Alternatively, gradual 're-loading' of respiratory muscles over time by reducing the NAVA level, with an option to schedule periods of nocturnal rest (eg using a synchronised control mode) may also prove a reasonable approach.
EAdi monitoring can inform the weaning process in a number of ways. As recovery occurs, neuro-ventilatory coupling becomes more efficient and so the EAdi is lower with the same degree of support. In terms of weaning, reducing the NAVA level at this stage should lead to only a minimal drop in Vt and Paw and only a small rise in EAdi. Monitoring of neural demand has also shown potential as an adjunct to traditional predictors for extubation success such as the rapid shallow breathing index. 22 Overall, it is likely that a protocolised weaning schedule will provide better outcomes than ad hoc weaning of NAVA levels, as has been shown in numerous ventilatory weaning studies. 45
Non-invasive ventilation (NIV)
Given that air leaks during NIV lead to profound patientventilator asynchrony, this seems a logical place for the use of NAVA. 46 The main limiting factors are the need for NG insertion and that NIV must be driven through a Servo-I ventilator. Several centres in Europe use this technique and have demonstrated improved synchrony. 47, 48 However, there remains limited evidence for outcome benefits compared to alternate interfaces. 49, 50 
Summary
Neurally-adjusted ventilation assist provides a novel way to enhance patient-ventilator synchrony. Critically, it is not dependent on the presence of an endotracheal tube and noninvasive systems are commercially available. Its method of signal detection is minimally invasive and is stable over time. Independent of the signal' s ability to drive ventilatory support, the EAdi provides an invaluable monitor of neural demand that can be informative even post-extubation. Although it does not provide a ventilatory panacea, NAVA is effective in a wide number of clinical settings.
However, despite some key theoretical advantages over conventional modes, no randomised controlled trial data exist to substantiate these. Even more fundamentally, there is no clear evidence base for either optimal initiation of NAVA support or best practice for weaning it. A recent roundtable report suggests that a consensus of how best to apply this technology is not far away. 38 The introduction of NAVA to our own institution required a significant investment in research nurse and practice development nurse time. The formation of a super-user group to develop protocols, ensure the safe and effective use of this technology and perform parallel translational research has been critical. Overall, it is our belief that the time and effort we have invested in NAVA has been repaid. The system provides insight into pulmonary mechanics and physiology and enhances interprofessional use of ventilatory support. Finally, NAVA makes teleological sense, is intuitive to use and reinforces other ventilatory practices that do have a strong evidence base for saving lives and money.
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